Risk factors of chemotherapy-induced nausea and vomiting in patients with metastatic colorectal cancer: a prospective cohort study (YCOG1301).

Shogo Takei Atsushi IshibeJun WatanabeKazuteru WatanabeYusuke SuwaShinsuke SuzukiKazuya NakagawaHirokazu SuwaMitsuyoshi OtaYasushi IchikawaChikara KunisakiTakeharu YamanakaItaru Endo

Published in: International journal of colorectal disease (2020)

This study failed to identify any single risk factors associated with delayed CINV in patients who received chemotherapy for advanced colorectal cancer. However, combinations of "thin and women" or "young and thin patients" might be possible predictive conditions, thus, candidates for NK1 receptor antagonist administration in MEC. Further investigations are required to develop criteria for the supplementation of NK1 receptor antagonist.

Keyphrases

chemotherapy induced
metastatic colorectal cancer
risk factors
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
type diabetes
nk cells
squamous cell carcinoma
adipose tissue
radiation therapy
pregnancy outcomes
rectal cancer